Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study to Investigate the Safety, Tolerability , Pharmacokinetics of Single Ascending Dose of MT-3921 in Subjects With Acute Spinal Cord Injury

NCT04096950 is registered in ClinicalTrials.gov with Tanabe Pharma America, Inc. as lead sponsor.

NCT NCT04096950
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04096950 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study to Investigate the Safety, Tolerability , Pharmacokinetics of Single Ascending Dose of MT-3921 in Subjects With Acute Spinal Cord Injury
Lead sponsor
Tanabe Pharma America, Inc.
Phase
Phase 1
Overall status
Completed
Start date
April 19, 2020
Completion date
January 6, 2021
Enrollment
3 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

spinal cord injury